Explore

Trendline Trendline
Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Initiatives

Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Initiatives

Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Initiatives
Trendline Trendline
Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Phase

Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Phase

Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Phase
Trendline Trendline
Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth

Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth

Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth
Trendline Trendline
Arrowhead Pharmaceuticals Reports Positive Phase 3 Data for Triglyceride-Lowering Drug, Challenging Ionis

Arrowhead Pharmaceuticals Reports Positive Phase 3 Data for Triglyceride-Lowering Drug, Challenging Ionis

Arrowhead Pharmaceuticals Reports Positive Phase 3 Data for Triglyceride-Lowering Drug, Challenging Ionis
Trendline Trendline
Atossa Therapeutics Presents (Z)-Endoxifen Data for McCune-Albright Syndrome

Atossa Therapeutics Presents (Z)-Endoxifen Data for McCune-Albright Syndrome

Atossa Therapeutics Presents (Z)-Endoxifen Data for McCune-Albright Syndrome
Trendline Trendline
PwC Canada Announces New Leadership Team Under CEO Domenic Marino

PwC Canada Announces New Leadership Team Under CEO Domenic Marino

PwC Canada Announces New Leadership Team Under CEO Domenic Marino
Trendline Trendline
TELUS Announces Executive Changes to Drive Sustainable Growth in Telecom Business

TELUS Announces Executive Changes to Drive Sustainable Growth in Telecom Business

TELUS Announces Executive Changes to Drive Sustainable Growth in Telecom Business
Trendline Trendline
Aspen Pharmacare Canada Gains Health Canada Approval for Generic Ozempic, Expanding Diabetes Treatment Options

Aspen Pharmacare Canada Gains Health Canada Approval for Generic Ozempic, Expanding Diabetes Treatment Options

Aspen Pharmacare Canada Gains Health Canada Approval for Generic Ozempic, Expanding Diabetes Treatment Options
Trendline Trendline
Agios Pharmaceuticals Discontinues Sickle Cell Drug Candidate After Failing to Outperform Competitors

Agios Pharmaceuticals Discontinues Sickle Cell Drug Candidate After Failing to Outperform Competitors

Agios Pharmaceuticals Discontinues Sickle Cell Drug Candidate After Failing to Outperform Competitors
Trendline Trendline
AstraZeneca Faces Challenges in Reaching $80 Billion Sales Target After Wainua Setback

AstraZeneca Faces Challenges in Reaching $80 Billion Sales Target After Wainua Setback

AstraZeneca Faces Challenges in Reaching $80 Billion Sales Target After Wainua Setback
Trendline Trendline
PwC Canada Announces New Leadership Team to Navigate AI-Driven Opportunities

PwC Canada Announces New Leadership Team to Navigate AI-Driven Opportunities

PwC Canada Announces New Leadership Team to Navigate AI-Driven Opportunities
Reuters Reuters
Bristol Myers buys Nvidia's latest AI computing system for drug research

Bristol Myers buys Nvidia's latest AI computing system for drug research

By Michael Erman NEW YORK, July 20 (Reuters) - Bristol Myers Squibb said on Monday it is buying the latest-generation computing system from chip company Nvidia to support its use of artificial intelligence across its drug discovery and development operations.